公开(公告)号：US20220289846A1

公开(公告)日：2022-09-15

申请号：US17625551

申请日：2020-07-09

申请人： CADILA HEALTHCARE LIMITED

发明人： Sanjeev Kumar MENDIRATTA ,  Kaushik BANERJEE ,  Dipti MEHTA ,  Ramkrashan KASERA ,  Arun SINGH ,  Aashini PARIKH ,  Pankaj KALITA ,  Ritu UPADHYAY ,  Vibhuti SHARMA ,  Hardik PANDYA

IPC分类号： C07K16/28 ,  A61K51/10 ,  A61K47/68 ,  C07K16/32

摘要： The present invention relates to an antibody or antigen-binding portion thereof that can bind to human programmed death 1 (PD-1). The antibody according to the present invention is further used in the preparation of a drug for treating disease in which expression of PD-1 is detrimental.